Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
2,026,123
-
Share change
-
-793,868
-
Total reported value
-
$11,884,000
-
Price per share
-
$5.88
-
Number of holders
-
7
-
Value change
-
-$4,501,597
-
Number of buys
-
2
-
Number of sells
-
4
Institutional Holders of INTEC PHARMA LTD JERUSALEM - SHS as of Q3 2016
As of 30 Sep 2016 INTEC PHARMA LTD JERUSALEM - SHS had 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,026,123 shares of stock of the company.
Largest 7 holders included Cormorant Asset Management, LLC, SABBY MANAGEMENT, LLC, Migdal Insurance & Financial Holdings Ltd., Opaleye Management Inc., RENAISSANCE TECHNOLOGIES LLC, DEUTSCHE BANK AG\, and UBS Group AG.
This table shows 7 institutional shareholders of the security as of 30 Sep 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.